Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Experimental and Therapeutic Medicine
|
January 21, 2017
Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver
Maoqin Li, Jingxi Sun, Jiaqiong Li, et al.
Redox Biology
|
April 18, 2022
Corrigendum to "Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch" [Redox Biol. 52 (2022) 1-16/102311]
Mingge Ding, Rui Shi, Shuli Cheng, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 18, 2012
Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis
Nan Yang, Guang Wang, Chenghu Hu, et al.
Redox Biology
|
April 12, 2022
Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch
Mingge Ding, Rui Shi, Shuli Cheng, et al.
Nature Communications
|
November 17, 2022
N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA
Xiang Zhang, Huilong Yin, Xiaofang Zhang, et al.
Cellular & Molecular Biology Letters
|
February 2, 2024
IP<sub>3</sub>R1-mediated MAMs formation contributes to mechanical trauma-induced hepatic injury and the protective effect of melatonin
Rui Shi, Zhenhua Liu, Huan Yue, et al.
Cell Metabolism
|
April 3, 2025
O-GlcNAcylation-mediated endothelial metabolic memory contributes to cardiac damage via small extracellular vesicles
Mingge Ding, Rui Shi, Yanyan Du, et al.
Frontiers in Neurology
|
January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
March 20, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
Cephalalgia : an International Journal of Headache
|
April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraine, summary version
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Experimental and Therapeutic Medicine
|
January 21, 2017
Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver
Maoqin Li, Jingxi Sun, Jiaqiong Li, et al.
Redox Biology
|
April 18, 2022
Corrigendum to "Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch" [Redox Biol. 52 (2022) 1-16/102311]
Mingge Ding, Rui Shi, Shuli Cheng, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 18, 2012
Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis
Nan Yang, Guang Wang, Chenghu Hu, et al.
Redox Biology
|
April 12, 2022
Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch
Mingge Ding, Rui Shi, Shuli Cheng, et al.
Nature Communications
|
November 17, 2022
N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA
Xiang Zhang, Huilong Yin, Xiaofang Zhang, et al.
Cellular & Molecular Biology Letters
|
February 2, 2024
IP<sub>3</sub>R1-mediated MAMs formation contributes to mechanical trauma-induced hepatic injury and the protective effect of melatonin
Rui Shi, Zhenhua Liu, Huan Yue, et al.
Cell Metabolism
|
April 3, 2025
O-GlcNAcylation-mediated endothelial metabolic memory contributes to cardiac damage via small extracellular vesicles
Mingge Ding, Rui Shi, Yanyan Du, et al.
Frontiers in Neurology
|
January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
March 20, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
Cephalalgia : an International Journal of Headache
|
April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraine, summary version
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Page
of 5